Literature DB >> 28842732

[Preclinical use of mild therapeutic hypothermia after cardiac arrest by the emergency services in Baden-Württemberg, Germany].

R Fantin1, B Schmid1, C Busche1, H Fritz2, K Fink1, H-J Busch3.   

Abstract

BACKGROUND: During the last decade target temperature management has become an integral part of postresuscitation care. Within recent years there was a strong debate about the optimal target temperature, which might have effects on the preclinical induction of hypothermia. The present investigation focuses on the use of mild therapeutic hypothermia by emergency services in the state of Baden-Württemberg (Germany) and compares it to results of a prior study in 2008.
METHODS: Between April and August 2014 a questionnaire was sent to all senior emergency physicians of emergency services in Baden Württemberg. The survey period was April to August of 2014. Parts of the questionnaire were similar to a previous one in 2008, to ensure comparability to the former data; other parts were added to set new focuses. The data were analyzed in anonymized form.
RESULTS: The response rate was 72.4% (97/134). Of the 97 sites which responded to the questionnaire significantly more use preclinical hypothermia, compared to 2008 (72.2% [70/97] vs. 41.7%); 62.9% (44/70) declare cooling resuscitated patients routinely (vs. 17.7% in 2008). Cold infusions (85.7%), icepacks (64.3%), passive cooling (37.1%), nasal cooling (2.9%) and cooling caps (1.4%) are used (multiple naming was possible). Sites that did not use mild therapeutic hypothermia stated the following reasons: lack of equipment, short transport time and missing data for the intervention. Four sites reported on complications with therapeutic hypothermia.
CONCLUSION: The present investigation shows an increased use of preclinical cooling after cardiopulmonary resuscitation as compared to 2008. Therefore, recent discussions concerning the optimal target temperature in postresuscitation care did not result in a waiving of preclinical therapeutic strategies in Baden-Württemberg. The emergency services sites/locations estimated the complication rates of mild therapeutic hypothermia as very low. Lack of equipment seems to be the main reason to refuse the preclinical use of therapeutic hypothermia. In conclusion, preclinical mild therapeutic hypothermia has become an integral part in the standard care of resuscitated patients in Baden-Württemberg.

Entities:  

Keywords:  Cardiac arrest; Care Management; Emergency care; Preclinical treatment; TTM therapy; Therapeutic hypothermia

Mesh:

Year:  2017        PMID: 28842732     DOI: 10.1007/s00063-017-0338-1

Source DB:  PubMed          Journal:  Med Klin Intensivmed Notfmed        ISSN: 2193-6218            Impact factor:   0.840


  10 in total

Review 1.  Part 9: post-cardiac arrest care: 2010 American Heart Association Guidelines for Cardiopulmonary Resuscitation and Emergency Cardiovascular Care.

Authors:  Mary Ann Peberdy; Clifton W Callaway; Robert W Neumar; Romergryko G Geocadin; Janice L Zimmerman; Michael Donnino; Andrea Gabrielli; Scott M Silvers; Arno L Zaritsky; Raina Merchant; Terry L Vanden Hoek; Steven L Kronick
Journal:  Circulation       Date:  2010-11-02       Impact factor: 29.690

2.  Mild therapeutic hypothermia after cardiac arrest - a nationwide survey on the implementation of the ILCOR guidelines in German intensive care units.

Authors:  Sebastian Wolfrum; Peter W Radke; Tobias Pischon; Stefan N Willich; Heribert Schunkert; Volkhard Kurowski
Journal:  Resuscitation       Date:  2006-11-13       Impact factor: 5.262

3.  Targeted temperature management at 33°C versus 36°C after cardiac arrest.

Authors:  Niklas Nielsen; Jørn Wetterslev; Tobias Cronberg; David Erlinge; Yvan Gasche; Christian Hassager; Janneke Horn; Jan Hovdenes; Jesper Kjaergaard; Michael Kuiper; Tommaso Pellis; Pascal Stammet; Michael Wanscher; Matt P Wise; Anders Åneman; Nawaf Al-Subaie; Søren Boesgaard; John Bro-Jeppesen; Iole Brunetti; Jan Frederik Bugge; Christopher D Hingston; Nicole P Juffermans; Matty Koopmans; Lars Køber; Jørund Langørgen; Gisela Lilja; Jacob Eifer Møller; Malin Rundgren; Christian Rylander; Ondrej Smid; Christophe Werer; Per Winkel; Hans Friberg
Journal:  N Engl J Med       Date:  2013-11-17       Impact factor: 91.245

Review 4.  Temperature management after cardiac arrest.

Authors:  Niklas Nielsen; Hans Friberg
Journal:  Curr Opin Crit Care       Date:  2015-06       Impact factor: 3.687

5.  Use of target temperature management after cardiac arrest in Germany--a nationwide survey including 951 intensive care units.

Authors:  C Storm; T Meyer; T Schroeder; A Wutzler; A Jörres; C Leithner
Journal:  Resuscitation       Date:  2014-05-02       Impact factor: 5.262

6.  Epidemiology and management of cardiac arrest: what registries are revealing.

Authors:  Jan-Thorsten Gräsner; Leo Bossaert
Journal:  Best Pract Res Clin Anaesthesiol       Date:  2013-09

7.  Mild therapeutic hypothermia to improve the neurologic outcome after cardiac arrest.

Authors: 
Journal:  N Engl J Med       Date:  2002-02-21       Impact factor: 91.245

8.  Treatment of comatose survivors of out-of-hospital cardiac arrest with induced hypothermia.

Authors:  Stephen A Bernard; Timothy W Gray; Michael D Buist; Bruce M Jones; William Silvester; Geoff Gutteridge; Karen Smith
Journal:  N Engl J Med       Date:  2002-02-21       Impact factor: 91.245

9.  Induction of Therapeutic Hypothermia During Out-of-Hospital Cardiac Arrest Using a Rapid Infusion of Cold Saline: The RINSE Trial (Rapid Infusion of Cold Normal Saline).

Authors:  Stephen A Bernard; Karen Smith; Judith Finn; Cindy Hein; Hugh Grantham; Janet E Bray; Conor Deasy; Michael Stephenson; Teresa A Williams; Lahn D Straney; Deon Brink; Richard Larsen; Chris Cotton; Peter Cameron
Journal:  Circulation       Date:  2016-08-25       Impact factor: 29.690

10.  Effect of prehospital induction of mild hypothermia on survival and neurological status among adults with cardiac arrest: a randomized clinical trial.

Authors:  Francis Kim; Graham Nichol; Charles Maynard; Al Hallstrom; Peter J Kudenchuk; Thomas Rea; Michael K Copass; David Carlbom; Steven Deem; W T Longstreth; Michele Olsufka; Leonard A Cobb
Journal:  JAMA       Date:  2014-01-01       Impact factor: 56.272

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.